A week after the New York Times ran an article about a $20 billion health care startup that could one day lead the way in the world of healthcare, the startup is now hiring in-house engineers.
In fact, the company is hiring for as many as 300 positions, according to the New England Journal of Medicine.
But while the Times story was great for attracting the attention of healthcare professionals and industry watchers, the hiring of engineers in-person is not.
The company, which also sells medical software, is working to hire in-houses as soon as possible, according the company.
As part of that, the NYT piece focused on the idea that startups like Sutter Health could eventually lead the industry in health technology.
But there is another piece of the puzzle that has people wondering if this is a bubble.
Here’s what’s going on.
In a few weeks, we’ll get to a few of the startups and their hiring.
Here are some of the big takeaways: Sutter is hiring in house engineers as part of its effort to grow the health care workforce.
The NYT article is a good example of this.
It mentions that the company has hired in-depth health and life sciences teams for a variety of roles including “the team of doctors, nurses, and technologists tasked with creating the system that will determine the safety and efficacy of its new treatment.”
But the NYT article does not address why that would be the case.
The article does mention that Sutter has hired engineers for a “new approach to health care” called a “vascular technology program,” but there’s no mention of why it’s hiring in in-home engineers.
Sutter will use the in-homes to conduct its research, develop new treatments, and test new products.
This approach is what the company describes as “an approach to medical technology and patient care that combines the best of both worlds.”
The company has said it plans to offer health benefits to its patients via a combination of home-based medical technology as well as devices such as implanted cardio-pulmonary monitors and other devices that can be connected to the internet and used to monitor vital signs.
As a result, the team will work on “the best way to help people in a variety.
of healthcare settings,” the NYT writes.
The team will be “building a new system to help patients better understand their medical conditions, as well to better manage and manage their disease.”
In a statement to Polygon, a spokesperson for Sutter said the company would not be discussing the hiring process with the Times.
In an email, Sutter says that “as a company, we hire for a number of reasons, including the number of employees we have on staff and the complexity of our business.
We also hire in person for a wide range of roles, including product, engineering, marketing, and sales, with a strong focus on product development, testing, and quality assurance.”
The NYT story was not the first time that the NYT mentioned that Suter was hiring in homes.
In March, the Times also reported that Suthers research group, called the “Health Innovation Lab,” was working to develop a blood test called HemeScan, which would “provide new, personalized, and efficient ways of diagnosing and treating hemolytic uremic syndrome (HUS).”
The HemeScans could potentially replace existing tests that can test for other diseases, such as HIV and other blood disorders, according a recent report by the Journal of Clinical Endocrinology & Metabolism.
However, the Hemescan company says it is not interested in using the technology in healthcare.
The Hemescans use the blood of a person who is suffering from HUS, rather than that of a healthy person.
“The HemesScan is not being developed for use in healthcare and is not intended to be a replacement for existing diagnostic tests,” the company wrote in a statement emailed to Polygons reporters.
The story does note that the lab’s efforts were not just focused on developing a test for HUS.
“In addition to the Hemes Scan, the HUS Lab will develop a suite of new products that will improve the performance of existing testing,” the statement said.
In addition to testing for other disease-related issues, the lab plans to develop and sell new technologies, including devices that monitor blood flow and help prevent blood clots.
The lab says it has already received $3 million from the company to help fund the development of the products.
The Sutter Healthcare team, meanwhile, says it’s focused on health care as its primary focus.
“Our mission is to accelerate the delivery of healthcare by creating solutions that provide improved patient outcomes and improve patient care,” the team said in a press release.
“We want to build a world-class team of health professionals who will be able to lead in-service and on-site solutions.”
In addition, the Sutter team says that the team is committed